Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIZN
3151
DELISTED
Citizens Holding Co.
CIZN
| $324K | ﹤0.01% |
15,700
+800
| +5% | +$17.2K |
|
3152
Cerus
CERS
$575M
| $322K | ﹤0.01% |
57,341
-203,859
| -78% | -$1.13M |
|
3153
Macy's
M
$6.51B
| $321K | ﹤0.01% |
14,964
-3,578,300
| -100% | -$81.4M |
|
3154
Intrepid Potash
IPI
$476M
| $320K | ﹤0.01% |
+9,520
| New | +$332K |
|
|
LUB
3155
DELISTED
Luby's Inc.
LUB
| $320K | ﹤0.01% |
295,884
+10,700
| +4% | +$14.6K |
|
|
AVDR
3156
DELISTED
Avedro, Inc Common Stock
AVDR
| $320K | ﹤0.01% |
+16,300
| New | +$261K |
|
|
XYZ
3157
Block Inc
XYZ
$48.9B
| $319K | ﹤0.01% |
4,400
-1,150,500
| -100% | -$80.4M |
|
|
CRESY
3158
Cresud
CRESY
$806M
| $318K | ﹤0.01% |
+32,377
| New | +$312K |
|
3159
iShares Russell Top 200 Growth ETF
IWY
$15.2B
| $317K | ﹤0.01% |
+3,700
| New | +$311K |
|
|
ESBK
3160
DELISTED
Elmira Savings Bank Elmira NY
ESBK
| $316K | ﹤0.01% |
19,685
-200
| -1% | -$3.29K |
|
3161
Electro-Sensors
ELSE
$27.3M
| $314K | ﹤0.01% |
94,600
+3,000
| +3% | +$10.5K |
|
|
GNMX
3162
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $313K | ﹤0.01% |
1,955,391
+863,474
| +79% | +$175K |
|
|
KEG
3163
DELISTED
Key Energy Services, Inc. Common Stock
KEG
| $311K | ﹤0.01% |
138,020
+36,400
| +36% | +$109K |
|
3164
Sonoma Pharmaceuticals
SNOA
$5.26M
| $310K | ﹤0.01% |
1,955
+454
| +30% | +$69.7K |
|
|
ALNA
3165
DELISTED
Allena Pharmaceuticals
ALNA
| $310K | ﹤0.01% |
76,200
+61,400
| +415% | +$335K |
|
3166
Esquire Financial Holdings
ESQ
$1.14B
| $309K | ﹤0.01% |
+12,300
| New | +$290K |
|
3167
First Trust North American Energy Infrastructure Fund
EMLP
$4.1B
| $307K | ﹤0.01% |
+12,200
| New | +$303K |
|
3168
Global Partners
GLP
$1.65B
| $305K | ﹤0.01% |
15,300
+494
| +3% | +$9.82K |
|
|
TCDA
3169
DELISTED
Tricida, Inc. Common Stock
TCDA
| $304K | ﹤0.01% |
+7,700
| New | +$271K |
|
3170
iShares Global 100 ETF
IOO
$8.62B
| $303K | ﹤0.01% |
+6,200
| New | +$300K |
|
3171
iShares Expanded Tech Sector ETF
IGM
$9.57B
| $302K | ﹤0.01% |
+8,400
| New | +$297K |
|
3172
Armata Pharmaceuticals
ARMP
$168M
| $300K | ﹤0.01% |
74,854
+29,594
| +65% | +$113K |
|
3173
Cemtrex
CETX
$4.32M
| – | – |
0
| – | – |
|
3174
Futu Holdings
FUTU
$14.3B
| $299K | ﹤0.01% |
+28,300
| New | +$364K |
|
3175
Wrap Technologies
WRAP
$90.9M
| $299K | ﹤0.01% |
+48,100
| New | +$328K |
|
Similar funds
Renaissance Technologies's Q2 2019 Portfolio in Review
As of Q2 2019, Renaissance Technologies held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Renaissance Technologies added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Renaissance Technologies's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Renaissance Technologies fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Renaissance Technologies opened 495 new positions and closed 397 in Q2 2019.
- Renaissance Technologies's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.